15-04-2025
Middle Eastern Penny Stocks With Market Caps Over US$0
Most Gulf markets have recently experienced gains, supported by easing trade tensions following U.S. tariff exemptions on certain electronics, which has positively influenced indices across the region. For investors interested in exploring beyond the well-known companies, penny stocks—despite their somewhat outdated name—remain a relevant area of interest. These smaller or newer companies often possess solid financial foundations and potential for significant returns, offering intriguing opportunities for those willing to explore them further.
Name
Share Price
Market Cap
Financial Health Rating
Thob Al Aseel (SASE:4012)
SAR4.04
SAR1.62B
★★★★★★
Keir International (SASE:9542)
SAR3.93
SAR471.6M
★★★★★☆
Alarum Technologies (TASE:ALAR)
₪2.782
₪192.91M
★★★★★★
Oil Refineries (TASE:ORL)
₪0.949
₪2.95B
★★★★★☆
Tarya Israel (TASE:TRA)
₪0.578
₪171.58M
★★★★★☆
Tgi Infrastructures (TASE:TGI)
₪2.173
₪161.55M
★★★★★★
Union Properties (DFM:UPP)
AED0.523
AED2.26B
★★★★☆☆
Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC)
AED0.735
AED450.11M
★★★★★★
E7 Group PJSC (ADX:E7)
AED1.02
AED2.06B
★★★★★★
Dubai Investments PJSC (DFM:DIC)
AED2.44
AED10.37B
★★★★☆☆
Click here to see the full list of 96 stocks from our Middle Eastern Penny Stocks screener.
Let's explore several standout options from the results in the screener.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Apex Investment PSC manufactures, distributes, and sells clinkers and cement products in the United Arab Emirates and internationally, with a market cap of AED14.50 billion.
Operations: The company's revenue is primarily derived from its Catering segment at AED595.66 million, followed by Manufacturing at AED235.34 million, Facility Management Services at AED106.16 million, and Contracting at AED38.01 million within the United Arab Emirates and beyond.
Market Cap: AED14.5B
Apex Investment PSC has shown a significant turnaround by becoming profitable in the past year, reporting net income of AED75.64 million for 2024 compared to a net loss the previous year. With sales reaching AED852.85 million, the company's primary revenue streams are its Catering and Manufacturing segments. Apex's balance sheet is strong with no debt and short-term assets exceeding both short and long-term liabilities, providing financial stability. However, its earnings were impacted by a large one-off loss of AED57.9 million, and its Return on Equity remains low at 3.8%. The stock has experienced high volatility recently but maintains stable weekly volatility over the past year.
Navigate through the intricacies of Apex Investment PSC with our comprehensive balance sheet health report here.
Assess Apex Investment PSC's previous results with our detailed historical performance reports.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Ihlas Holding A.S. operates in construction and real estate, media, manufacturing and trading, as well as healthcare and education sectors both in Turkey and internationally, with a market cap of TRY3.34 billion.
Operations: The company's revenue is primarily derived from marketing (TRY4.22 billion), media (TRY2.29 billion), and construction (TRY1.88 billion) sectors.
Market Cap: TRY3.34B
Ihlas Holding A.S. has demonstrated financial resilience despite reporting a net loss of TRY1.38 billion for 2024, compared to a net income the previous year. The company's debt management is commendable, with its debt-to-equity ratio significantly reduced to 4.9% over five years and more cash on hand than total debt. Short-term assets of TRY13.7 billion cover both short and long-term liabilities, indicating robust liquidity. However, Ihlas remains unprofitable with a negative return on equity of -18.34%. Management stability is evident with an experienced team averaging 13.3 years in tenure, though share price volatility persists recently.
Click here and access our complete financial health analysis report to understand the dynamics of Ihlas Holding.
Evaluate Ihlas Holding's historical performance by accessing our past performance report.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Imed Infinity Medical-Limited Partnership is a research and development partnership that invests in medical field projects, particularly in digital health, with a market cap of ₪3.65 million.
Operations: Imed Infinity Medical-Limited Partnership has not reported any revenue segments.
Market Cap: ₪3.65M
Imed Infinity Medical-Limited Partnership, with a market cap of ₪3.65 million, is a pre-revenue entity focused on digital health projects. Despite being debt-free and having short-term assets ($896K) that exceed liabilities ($112K), the company remains unprofitable with losses increasing by 15.8% annually over five years. Recent earnings results show an improvement in net loss to US$0.575 million from US$1.77 million the previous year, reflecting reduced basic and diluted loss per share from continuing operations at US$0.14 compared to US$0.44 prior year-end December 2024, indicating some cost management progress amidst ongoing challenges.
Dive into the specifics of Imed Infinity Medical-Limited Partnership here with our thorough balance sheet health report.
Examine Imed Infinity Medical-Limited Partnership's past performance report to understand how it has performed in prior years.
Click through to start exploring the rest of the 93 Middle Eastern Penny Stocks now.
Ready To Venture Into Other Investment Styles? These 12 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ADX:APEX IBSE:IHLAS and TASE:IMED.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
